Ikris Pharma International SRL
Ikris Pharma International reported total assets of 151,039 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jul 2026).
The score of Ikris Pharma International shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -34 % Total assets -72 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ikris Pharma International's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Ikris Pharma International's financial analysis
- Solvency42.1%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ikris Pharma International
Ikris Pharma International's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0642.608.172
- VAT number
- BE0642608172
- Peppol
- Registered · 0208:0642608172 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Nov 2015
- Registered office
- 4821 Dison
- Latest accounts
- 2025 · filed on 17 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Ikris Pharma International (SRL) has been based in Dison since 2015, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 10,483 € and equity of 63,628 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ikris Pharma International
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- NBS Scientific Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 152,659 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- O Care Pharma Wholesale of pharmaceutical and medical goods Hasselt · balance sheet 147,746 €
Frequently asked questions about Ikris Pharma International
What is the revenue of Ikris Pharma International?
Ikris Pharma International files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ikris Pharma International?
In Belgium, the VAT number is the company number prefixed with BE: BE0642608172 for Ikris Pharma International, if the company is VAT-registered. Its company number (CBE) is 0642.608.172.
Where is the registered office of Ikris Pharma International?
According to the CBE register, the registered office of Ikris Pharma International is in 4821 Dison.
What is the equity of Ikris Pharma International?
At the close of the 2025 financial year, the equity of Ikris Pharma International amounts to 63,628 €, a solvency of 42.1% of total assets.
Who manages Ikris Pharma International?
The register lists 2 active mandates at Ikris Pharma International. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ikris Pharma International
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →